Table 3 The prognostic value of different clinical parameters in the testing group

Age

1.00

0.98–1.02

0.899

1.00

0.98–1.02

0.828

Gender

0.96

0.57–1.61

0.869

0.98

0.56–1.70

0.929

Stage

1.69

1.28–2.23

<0.001***

1.81

0.74–4.39

0.192

T

1.64

1.27–2.13

<0.001***

0.90

0.37–2.20

0.825

M

1.33

0.76–2.34

0.315

1.78

0.91–3.49

0.093

N

1.00

0.55–1.82

0.995

0.75

0.35–1.58

0.445

Risk score

1.12

1.04–1.21

0.002**

1.10

1.01–1.20

0.031*